Detalhe da pesquisa
1.
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
Nat Immunol
; 25(2): 282-293, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172257
2.
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
Nat Immunol
; 25(4): 717, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347083
3.
CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes.
Blood
; 138(26): 2768-2780, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34086870
4.
A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease.
J Clin Immunol
; 42(1): 108-118, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655400
5.
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease.
Cytotherapy
; 23(3): 203-210, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33051095
6.
Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes.
J Biol Chem
; 294(37): 13638-13656, 2019 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337704
7.
An Update on XMEN Disease.
J Clin Immunol
; 40(5): 671-681, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451662
8.
Adult-onset neurodegeneration in XMEN disease.
J Neuroimmunol
; 386: 578251, 2024 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041964
9.
Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease.
J Clin Invest
; 130(1): 507-522, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714901
10.
Mg2+ regulation of kinase signaling and immune function.
J Exp Med
; 216(8): 1828-1842, 2019 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31196981